Bi-specific MHC Heterodimers for Characterization of Cross-reactive T Cells

被引:8
|
作者
Shen, Zu T.
Brehm, Michael A. [2 ]
Daniels, Keith A.
Sigalov, Alexander B.
Selin, Liisa K.
Welsh, Raymond M.
Stern, Lawrence J. [1 ,3 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Div Diabet, Worcester, MA 01655 USA
[3] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA
基金
美国国家卫生研究院;
关键词
HETEROLOGOUS ANTIVIRAL IMMUNITY; CRYSTAL-STRUCTURE; VIRUS; MEMORY; BINDING; TCR; CORECEPTOR; AFFINITY; ALPHA; RECOGNITION;
D O I
10.1074/jbc.M110.141051
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T cell cross-reactivity describes the phenomenon whereby a single T cell can recognize two or more different peptide antigens presented in complex with MHC proteins. Cross-reactive T cells have previously been characterized at the population level by cytokine secretion and MHC tetramer staining assays, but single-cell analysis is difficult or impossible using these methods. In this study, we describe development of a novel peptide MHC heterodimer specific for cross-reactive T cells. MHC-peptide monomers were independently conjugated to hydrazide or aldehyde-containing cross-linkers using thiol-maleimide coupling at cysteine residues introduced into recombinant MHC heavy chain proteins. Hydrazone formation provided bi-specific MHC heterodimers carrying two different peptides. Using this approach we prepared heterodimers of the murine class I MHC protein H-2K(b) carrying peptides from lymphocytic choriomeningitis virus and vaccinia virus, and used these to identify cross-reactive CD8+ T cells recognizing both lymphocytic choriomeningitis virus and vaccinia virus antigens. A similar strategy could be used to develop reagents to analyze cross-reactive T cell responses in humans.
引用
收藏
页码:33144 / 33153
页数:10
相关论文
共 50 条
  • [1] Bi-specific MHC heterodimers for the characterization of cross-reactive T cells
    Shen, Zu
    Brehm, Michael
    Daniels, Keith
    Sigalov, Alexander
    Selin, Liisa
    Welsh, Raymond
    Stern, Lawrence
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [2] Cross-reactive T cells
    Thiago Carvalho
    Nature Medicine, 2020, 26 : 1807 - 1807
  • [3] Cross-reactive T cells
    Carvalho, Thiago
    NATURE MEDICINE, 2020, 26 (12) : 1807 - 1807
  • [4] PROSTATE CANCER IMMUNOTHERAPY USING BI-SPECIFIC TUMOR-REACTIVE T CELLS
    Chan, Robert
    Leen, Ann
    Brenner, Malcolm
    Palapattu, Ganesh
    Vera, Juan
    JOURNAL OF UROLOGY, 2012, 187 (04): : E530 - E530
  • [5] Accumulation of allo-MHC cross-reactive memory T cells in bone marrow
    Hayama, Miyuki
    Shinohara, Nobukata
    Higashihara, Masaaki
    Eshima, Koji
    IMMUNOLOGY LETTERS, 2008, 117 (02) : 154 - 160
  • [6] Antigen-specific and cross-reactive T cells in protection and disease
    Jiang, Ning
    Malone, Michael
    Chizari, Shahab
    IMMUNOLOGICAL REVIEWS, 2023, 316 (01) : 120 - 135
  • [7] Why must T cells be cross-reactive?
    Andrew K. Sewell
    Nature Reviews Immunology, 2012, 12 : 669 - 677
  • [8] Why must T cells be cross-reactive?
    Sewell, Andrew K.
    NATURE REVIEWS IMMUNOLOGY, 2012, 12 (09) : 668 - 677
  • [9] Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive
    Hutnick, Natalie A.
    Carnathan, Diane
    Demers, Korey
    Makedonas, George
    Ertl, Hildegund C. J.
    Betts, Michael R.
    VACCINE, 2010, 28 (08) : 1932 - 1941
  • [10] Characterization of Cross-Reactive Norovirus-Specific Monoclonal Antibodies
    Kou, Baijun
    Crawford, Sue E.
    Ajami, Nadim J.
    Czako, Rita
    Neill, Frederick H.
    Tanaka, Tomoyuki N.
    Kitamoto, Noritoshi
    Palzkill, Timothy G.
    Estes, Mary K.
    Atmar, Robert L.
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (02) : 160 - 167